Bird flu tests are hard to get. So how will we know when to sound the pandemic alarm?

FHS
June 11, 2024
11:05 am

Stanford University infectious disease doctor Abraar Karan has seen a lot of patients with runny noses, fevers, and irritated eyes lately.

Gilead, Kite shorten Yescarta manufacturing by two days in ‘incremental’ improvement

Gilead and Kite announced Tuesday it received FDA approval to shorten its manufacturing process for the cell therapy Yescarta, a move expected to reduce the

January 31, 2024

Patent Filed by Lipocine Inc for Treating Testosterone Deficiency

Share this article According to GlobalData’s company profile on Lipocine, Nanoparticle drug conjugates was a key innovation area identified from patents. Lipocine‘s grant share as

April 4, 2024

Almirall to license Eloxx’s ZKN-013 for rare skin conditions

Share this article Almirall will develop and market the drug candidate for rare dermatological ailments. Credit: JPC-PROD / Shutterstock.com. Almirall has signed an exclusive licence

March 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.